Multiomics tools for improved atherosclerotic cardiovascular disease management

/
/
Multiomics tools for improved atherosclerotic cardiovascular disease management

Multiomics studies offer accurate preventive and therapeutic strategies for atherosclerotic cardiovascular disease (ASCVD) beyond traditional risk factors. By using artificial intelligence (AI) and machine learning (ML) approaches, it is possible to integrate multiple ‘omics and clinical data sets into tools that can be utilized for the development of personalized diagnostic and therapeutic approaches. However, currently multiple challenges in data quality, integration, and privacy still need to be addressed. In this opinion, we emphasize that joined efforts, exemplified by the AtheroNET COST Action, have a pivotal role in overcoming the challenges to advance multiomics approaches in ASCVD research, with the aim to foster more precise and effective patient care.

https://doi.org/10.1016/j.molmed.2023.09.004

Facebook
Twitter
LinkedIn
WhatsApp
Email

Latest Updates

The basics of RNA sequencing webinar on December 4, 2024
Dr. Ernest Diez Benavente from UMC Utretcht
Dr. Bram Slütter from Leiden University – Resident Memory T Cells in the Atherosclerotic Lesion...
InauguraI Journal Club Chats - Navigating PhD Supervision: expectations and realities with Melody Chemaly, Ignacio...
Macrophages and vascular inflammation by Postdocs Dr. Marie Piollet and Dr. Florentina Porsch.
Transcriptional regulation of cardiovascular gene expression” held by Dimitris Kardassis, Professor of Biochemistry at the...

Learn how we helped 100 top brands gain success